Loading…

The Final 10-Year Follow-Up Results From the BARI Randomized Trial

The Final 10-Year Follow-Up Results From the BARI (Bypass Angioplasty Revascularization Investigation) Randomized Trial Maria Mori Brooks, Edwin L. Alderman, Eric Bates, Martial Bourassa, Robert M. Califf, Bernard R. Chaitman, Katherine M. Detre, Frederick Feit, Robert L. Frye, Raymond J. Gibbons, R...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2007-04, Vol.49 (15), p.1600-1606
Main Authors: The BARI Investigators, BARI Investigators
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Final 10-Year Follow-Up Results From the BARI (Bypass Angioplasty Revascularization Investigation) Randomized Trial Maria Mori Brooks, Edwin L. Alderman, Eric Bates, Martial Bourassa, Robert M. Califf, Bernard R. Chaitman, Katherine M. Detre, Frederick Feit, Robert L. Frye, Raymond J. Gibbons, Regina M. Hardison, Mark A. Hlatky, David R. Holmes, Jr, Alice K. Jacobs, Sheryl F. Kelsey, Mary Krauland, William J. Rogers, Hartzell V. Schaff, Leonard Schwartz, Kim Sutton-Tyrrell, David O. Williams, Patrick L. Whitlow, for the BARI Investigators In the BARI (Bypass Angioplasty Revascularization Investigation) study, 1,829 patients with multivessel coronary artery disease were randomly assigned to percutaneous transluminal coronary balloon angioplasty (PTCA) or coronary artery bypass grafting (CABG) and followed up for an average of 10.4 years. The 10-year survival was 71.0% for PTCA and 73.5% for CABG (p = 0.18). The PTCA patients had substantially more subsequent revascularization procedures than the CABG group, but similar rates of angina. In the subgroup of patients with no treated diabetes, survival rates were nearly identical by randomization, whereas in the subgroup with treated diabetes, the CABG group had higher survival than the PTCA group (PTCA 45.5% vs. CABG 57.8%, p = 0.025).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2006.11.048